12:00 AM
Mar 05, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Mibefradil: Phase I started

Tau began a placebo-controlled, double-blind, U.S. Phase I trial to evaluate ascending doses of mibefradil given...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >